Brevan Howard Capital Management’s Elanco Animal Health ELAN Stock Holding History

Brevan Howard Capital Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,664	Closed	-$255K	–	2194
2026 Q1	$255K	Sell	10,664 -2,080	-16%	-$50.8K	﹤0.01%	1736
2025 Q4	$288K	Sell	12,744 -6,938	-35%	-$151K	﹤0.01%	1391
2025 Q3	$396K	Sell	19,682 -45,196	-70%	-$757K	﹤0.01%	1408
2025 Q2	$926K	Buy	64,878 +33,225	+105%	+$388K	0.01%	1106
2025 Q1	$332K	Sell	31,653 -68,582	-68%	-$776K	﹤0.01%	834
2024 Q4	$1.21M	Buy	100,235 +48,545	+94%	+$635K	0.01%	381
2024 Q3	$759K	Buy	51,690 +12,788	+33%	+$178K	0.01%	547
2024 Q2	$561K	Buy	+38,902	New	+$622K	0.01%	566

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Brevan Howard Capital Management's ELAN Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 10,664 shares — an estimated $255K sold.

Brevan Howard Capital Management first reported a position in ELAN in Q2 2024 and held it in 8 quarters. The position peaked at $1.21M in Q4 2024. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Brevan Howard Capital Management reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
Brevan Howard Capital Management sold 10,664 Elanco Animal Health shares in Q2 2026, an estimated $255K.
Brevan Howard Capital Management first reported a position in Elanco Animal Health in Q2 2024 and held it in 8 quarters.
Brevan Howard Capital Management's Elanco Animal Health position peaked at $1.21M in Q4 2024.
523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.